Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Specialty PACS Market, by Deployment Model
1.4.2 LAMEA Specialty PACS Market, by Type
1.4.3 LAMEA Specialty PACS Market, by End User
1.4.4 LAMEA Specialty PACS Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2017-2021)
3.3.2 Key Strategic Move: (Partnership, Collaborations and Agreements: 2017, Jul – 2022, Jan) Leading Players
Chapter 4. LAMEA Specialty PACS Market by Deployment Model
4.1 LAMEA On premises Market by Country
4.2 LAMEA Cloud-based Market by Country
Chapter 5. LAMEA Specialty PACS Market by Type
5.1 LAMEA Radiology PACS Market by Country
5.2 LAMEA Orthopedics PACS Market by Country
5.3 LAMEA Oncology PACS Market by Country
5.4 LAMEA Pathology PACS Market by Country
5.5 LAMEA Ophthalmology PACS Market by Country
5.6 LAMEA Women’s health PACS Market by Country
5.7 LAMEA Other Type Market by Country
Chapter 6. LAMEA Specialty PACS Market by End User
6.1 LAMEA Hospitals & Clinics Market by Country
6.2 LAMEA Ambulatory Surgical Centers Market by Country
6.3 LAMEA Others Market by Country
Chapter 7. LAMEA Specialty PACS Market by Country
7.1 Brazil Specialty PACS Market
7.1.1 Brazil Specialty PACS Market by Deployment Model
7.1.2 Brazil Specialty PACS Market by Type
7.1.3 Brazil Specialty PACS Market by End User
7.2 Argentina Specialty PACS Market
7.2.1 Argentina Specialty PACS Market by Deployment Model
7.2.2 Argentina Specialty PACS Market by Type
7.2.3 Argentina Specialty PACS Market by End User
7.3 UAE Specialty PACS Market
7.3.1 UAE Specialty PACS Market by Deployment Model
7.3.2 UAE Specialty PACS Market by Type
7.3.3 UAE Specialty PACS Market by End User
7.4 Saudi Arabia Specialty PACS Market
7.4.1 Saudi Arabia Specialty PACS Market by Deployment Model
7.4.2 Saudi Arabia Specialty PACS Market by Type
7.4.3 Saudi Arabia Specialty PACS Market by End User
7.5 South Africa Specialty PACS Market
7.5.1 South Africa Specialty PACS Market by Deployment Model
7.5.2 South Africa Specialty PACS Market by Type
7.5.3 South Africa Specialty PACS Market by End User
7.6 Nigeria Specialty PACS Market
7.6.1 Nigeria Specialty PACS Market by Deployment Model
7.6.2 Nigeria Specialty PACS Market by Type
7.6.3 Nigeria Specialty PACS Market by End User
7.7 Rest of LAMEA Specialty PACS Market
7.7.1 Rest of LAMEA Specialty PACS Market by Deployment Model
7.7.2 Rest of LAMEA Specialty PACS Market by Type
7.7.3 Rest of LAMEA Specialty PACS Market by End User
Chapter 8. Company Profiles
8.1 Novarad Enterprise Healthcare Solutions
8.1.1 Company Overview
8.1.2 Recent Strategies and developments:
8.1.2.1 Partnerships, Collaborations and Agreements:
8.1.2.2 Product Launches and Product Expansions:
8.2 Escalon Medical Corp.
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Regional Analysis
8.2.4 Research & Development Expenses
8.3 IBM Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional & Segmental Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent Strategies and developments:
8.3.5.1 Partnerships, Collaborations and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.4 Siemens AG
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 Recent Strategies and developments:
8.4.5.1 Partnerships, Collaborations and Agreements:
8.4.5.2 Product Launches and Product Expansions:
8.4.5.3 Acquisitions and Mergers:
8.4.6 SWOT Analysis
8.5 Canon, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 Recent Strategies and developments:
8.5.5.1 Partnerships, Collaborations and Agreements:
8.5.5.2 Product Launches and Product Expansions:
8.6 INFINITT Healthcare Co. Ltd.
8.6.1 Company Overview
8.6.2 Recent Strategies and developments:
8.6.2.1 Partnerships, Collaborations and Agreements:
8.7 Koninklijke Philips N.V.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 Recent Strategies and developments:
8.7.5.1 Product Launches and Product Expansions:
8.7.5.2 Acquisitions and Mergers:
8.8 McKesson Corporation
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental Analysis
8.8.4 Research & Development Expense
8.9 Carestream Health, Inc. (Onex Corporation)
8.9.1 Company Overview
8.10. Topcon Corporation
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Segmental and Regional Analysis
8.10.4 Recent Strategies and developments:
8.10.4.1 Partnerships, Collaborations and Agreements:
8.10.4.2 Acquisitions and Mergers:
Unique Offerings 